Inspire Medical Systems Income After Taxes 2017-2024 | INSP
Inspire Medical Systems annual/quarterly income after taxes history and growth rate from 2017 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Inspire Medical Systems income after taxes for the quarter ending September 30, 2024 was $0.018B, a 316.59% decline year-over-year.
- Inspire Medical Systems income after taxes for the twelve months ending September 30, 2024 was $0.033B, a 200.86% decline year-over-year.
- Inspire Medical Systems annual income after taxes for 2023 was $-0.021B, a 52.87% decline from 2022.
- Inspire Medical Systems annual income after taxes for 2022 was $-0.045B, a 6.75% increase from 2021.
- Inspire Medical Systems annual income after taxes for 2021 was $-0.042B, a 26.5% decline from 2020.
| Inspire Medical Systems Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $-21 |
| 2022 | $-45 |
| 2021 | $-42 |
| 2020 | $-57 |
| 2019 | $-33 |
| 2018 | $-22 |
| 2017 | $-18 |
| 2016 | $-19 |
| Inspire Medical Systems Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-09-30 | $18 |
| 2024-06-30 | $10 |
| 2024-03-31 | $-10 |
| 2023-12-31 | $15 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-12 |
| 2023-03-31 | $-15 |
| 2022-12-31 | $3 |
| 2022-09-30 | $-17 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-7 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-23 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $-8 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $-5 |
| 2017-03-31 | $-4 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.276B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| Enovis (ENOV) | United States | $2.529B | 17.15 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |